Walden Bjørn-yoshimoto is a founder and CEO with nine years of research-driven experience translating cone snail venom biology into neuroscientific and biomedical applications. As founder of Akasi Pharma and an Assistant Professor at the University of Copenhagen, he combines entrepreneurial leadership with hands-on molecular pharmacology and peptide discovery. His postdoctoral work focused on exploiting novel conotoxins as GPCR ligands, blending computational/bioinformatics approaches with in vitro pharmacology to deorphanize peptide–receptor interactions. Walden’s background spans academia and industry—from establishing mammalian cell labs at Evolva to research stays at NIMH and Harvard—giving him rare fluency in both translational science and lab infrastructure. He is particularly skilled at turning natural peptide diversity into targeted tools for neuroscience and drug discovery, often arriving at solutions that bridge computational predictions and bench validation.
9 years of coding experience
5 years of employment as a software developer
Cand.Scient, Biochemistry, Cand.Scient, Biochemistry at Københavns Universitet - University of Copenhagen
Contributions:24 commits, 18 pushes, 1 branch in 2 months
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.
Request Free Trial
Walden Bjørn-yoshimoto - Founder, CEO at Akasi Pharma